PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
19-Sep-2024 MHRA grants Benilexa® One Handed (52mg levonorgestrel intrauterine system [IUS]) an 8-year licence for contraception in the UK Gedeon Richter UK Ltd
19-Sep-2024 Biocomposites acquires remaining shares in manufacturers of SYNICEMTM and Subiton products Biocomposites
19-Sep-2024 Surgical Tourniquets Market Research, Driving Forces Analysis Report Pristine Market Insights
19-Sep-2024 Virtual Hospitals Market Set to Revolutionize Global Healthcare Delivery with Advanced Technologies Prophecy Market Insights
18-Sep-2024 Multi-Cancer Early Detection Market Forecast 2024-2034: Emerging Trends, Key Players, and Growth Opportunities Prophecy Market Insights
18-Sep-2024 GP industrial action will undo progress made in accessing surgeries: expert London Medical Laboratory
18-Sep-2024 Cordlife Unveils Enhanced Processing and Storage Facility in Singapore Cordlife Group Limited
18-Sep-2024 Exploring Growth of Artificial Intelligence (AI) in Biotechnology Prophecy Market Insights
17-Sep-2024 Improved breast cancer risk tools on the horizon as major study reaches 20-year halfway point The Institute of Cancer Research
17-Sep-2024 Aston University helps develop Healthcare Behaviour Insights Tool set to transform pharmaceutical launches across Europe Aston University
17-Sep-2024 Digital Cytology Report from IBMS and Hologic IBMS
17-Sep-2024 A global pharma showcase: MM Packaging readies for CPHI 2024 MM Packaging
17-Sep-2024 OrganaBio Expands Cell and Gene Therapy Donor Base to Include Patients with Lupus, Other Autoimmune Diseases OrganaBio
17-Sep-2024 ScaleReady announces a G-Rex® Grant has been awarded to Verismo Therapeutics Verismo Therapeutics
17-Sep-2024 Cell Line Development Market Set to Reach USD 13.9 Billion by 2032 Global Market Insights, Inc.
16-Sep-2024 Refeyn establishes new mass photometry Scientific Advisory Board to maximize potential of transformative technology Refeyn Ltd
16-Sep-2024 AAVantgarde announces first patient dosed in First-In-Human Phase 1/2 LUCE-1 study, evaluating AAVB-081 (Dual-AAV) in retinitis pigmentosa related to Usher Syndrome type 1B AAVantgarde Bio
16-Sep-2024 Certa Therapeutics Announces International Non-Proprietary Name for its First-in-class GPR68 Inhibitor Asengeprast (FT011) Certa Therapeutics
16-Sep-2024 Inauguration of the New Richter BioLogics cGMP Facility for the Manufacture of Biopharmaceuticals for the Global Market Richter BioLogics GmbH & Co KG
12-Sep-2024 NHSBSA releases latest mental health medicines statistics NHSBSA